Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Vaccines

Free Subscription 03.08.2026 1 AIDS 1 BMJ 1 Clin Infect Dis 1 Indian Pediatr 1 J Immunol 1 J Infect 1 J Infect Dis 3 J Virol 2 N Engl J Med 1 Nat Immunol 1 Nat Med 3 Pediatr Infect Dis J 1 PLoS Comput Biol 5 PLoS One 19 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. SUMNER T, Clark RA, Prys-Jones TO, Bakker R, et al
   New tuberculosis vaccines for people with HIV.
   AIDS. 2026 Jul 23. doi: 10.1097/QAD.0000000000004583.
   PubMed         Abstract available
   
   

   
   BMJ

2. LOGAN M
   US measles: Cases now surpass last year's total as vaccination rates decline.
   BMJ. 2026;394:e100437.
   PubMed        
   
   

   
   Clin Infect Dis

3. 
   Correction to: A Phase IV, Open-label, Single-Arm, Multicentric Clinical Trial for Evaluation of Human Papillomavirus 9vHPV Vaccine Immunogenicity in Men Who Have Sex With Men With HIV: GeSIDA Study 10 017.
   Clin Infect Dis. 2026 May 27:ciag318. doi: 10.1093.
   PubMed        
   
   

   
   Indian Pediatr

4. BANSAL D, Aaradhana, Kashyap B, Aggarwal A, et al
   Seroprotection Against Mumps in MMR Vaccinated Children Aged 9-12 Years: A Cross-Sectional Study.
   Indian Pediatr. 2026 Jul 30. doi: 10.1007/s13312-026-00406.
   PubMed         Abstract available
   
   

   
   J Immunol

5. CHEUNG MW, Choi JD, Stempak JM, Chandran V, et al
   T cell immunity to SARS-CoV-2 vaccination in inflammatory bowel disease patients treated with anti-cytokine biologics.
   J Immunol. 2026;215:vkag173.
   PubMed         Abstract available
   
   

   
   J Infect

6. SANZ-MUNOZ I, Ciria-Gil CJ, Hernandez M, Santiago C, et al
   Pre-existing and Cross-Reactive Immunity to Avian Influenza H5N1 in Humans: Implications for Pandemic Risk and Vaccine Strategies.
   J Infect. 2026 Jul 30:106822. doi: 10.1016/j.jinf.2026.106822.
   PubMed         Abstract available
   
   

   
   J Infect Dis

7. MIELLET WR, Almeida ST, Sa-Leao R, Trzcinski K, et al
   Correspondence to "Indirect Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Colonization: Persistence and Dynamics of Vaccine Serotypes in Sicily (Italy) 11 Years Postintroduction, 2009-2020" by Tramuto et al.
   J Infect Dis. 2026 Jul 29:jiag387. doi: 10.1093.
   PubMed        
   
   

   
   J Virol

8. REN J, Liu S, Yuan H, Wu Y, et al
   Enhanced replication and immunogenicity of a genome-modified non-replicating vaccinia virus Tiantan strain for robust low-dose protection in mice.
   J Virol. 2026 Jul 31:e0094326. doi: 10.1128/jvi.00943.
   PubMed         Abstract available
   
   
9. FARRIS L, Watts J, Pollet J, Molter C, et al
   Evaluation of a multiantigen mRNA vaccine against EEHV1A in Asian elephants.
   J Virol. 2026 Jul 28:e0038826. doi: 10.1128/jvi.00388.
   PubMed         Abstract available
   
   
10. WENNINGER M, Farris L, Heinz J, Peng R, et al
    First evidence of clinical protection from an EEHV1A mRNA vaccine in naturally infected juvenile elephants.
    J Virol. 2026 Jul 28:e0218625. doi: 10.1128/jvi.02186.
    PubMed         Abstract available
    
    

    
    N Engl J Med

11. WARKENTIN TE, Greinacher A
    Platelet-Activating Anti-Platelet Factor 4 Disorders.
    N Engl J Med. 2026 Jul 13. doi: 10.1056/NEJMra2502459.
    PubMed         Abstract available
    
    
12. WATANABE T, Koga M, Nojima M, Kono M, et al
    iEvac-Z, an Inactivated Ebola Vaccine - Phase 1 Study in Japan.
    N Engl J Med. 2026 Jul 29. doi: 10.1056/NEJMc2518666.
    PubMed        
    
    

    
    Nat Immunol

13. BERNARD NJ
    Towards a universal malaria vaccine.
    Nat Immunol. 2026;27:1531.
    PubMed        
    
    

    
    Nat Med

14. MADHI SA, Snaggs H, Skogeby Z, Feng Y, et al
    Maternal 6-valent group B Streptococcus vaccine in non-pregnant and pregnant females: a randomized phase 1/2 trial.
    Nat Med. 2026 Jul 28. doi: 10.1038/s41591-026-04558.
    PubMed         Abstract available
    
    

    
    Pediatr Infect Dis J

15. VURAL KINDAN SM, Erat T, Bulbul Oztoprak M, Bozelli BN, et al
    Varicella Zoster Virus Meningitis Mimicking Pseudotumor Cerebri Syndrome in an Immunocompetent Vaccinated Adolescent Without Rash or Meningeal Signs.
    Pediatr Infect Dis J. 2026 Jul 30. doi: 10.1097/INF.0000000000005352.
    PubMed        
    
    
16. BURSTAIN TL, Jacques D, Burstain JM
    Association Between First MMR Vaccination Before Age 2 Years and Childhood Autism in a U.S. EHR Cohort of 2.5 Million Children.
    Pediatr Infect Dis J. 2026 Jul 28. doi: 10.1097/INF.0000000000005349.
    PubMed         Abstract available
    
    
17. MORAN MC, Cates J, Balachandran N, Umana J, et al
    Evaluation of Rotavirus Vaccine Effectiveness by Severity of Rotavirus Disease: Findings From the MNSSTER-V Project.
    Pediatr Infect Dis J. 2026 Jul 28. doi: 10.1097/INF.0000000000005331.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

18. BEAULIEU M, Hoze N, Vieillefond V, Goetschy T, et al
    Quantitative analysis of massive SARS-CoV-2 testing in the community in France in 2021-2022 reveals the associations of variant, vaccination, and age with viral dynamics in symptomatic individuals.
    PLoS Comput Biol. 2026;22:e1013811.
    PubMed         Abstract available
    
    

    
    PLoS One

19. BUDGEY R, Bird M
    A simulation model to predict the most efficient way to utilise operational resources when vaccinating badgers against bTB.
    PLoS One. 2026;21:e0354329.
    PubMed         Abstract available
    
    
20. ABUSKA D, Dikme O, Dikme O, Yurttas TT, et al
    Age-stratified prognostic performance of hematologic inflammatory indices for 30-day mortality in emergency department patients with PCR-confirmed COVID-19: A cohort study from the pre-vaccination pandemic era.
    PLoS One. 2026;21:e0354809.
    PubMed         Abstract available
    
    
21. ZHAO Y, Wang Y, Song G, Luo H, et al
    Pyrococcus furiosus Argonaute coupled PCR assay for accurate discrimination between the MS-H vaccine strain and clinical isolates of Mycoplasma synoviae.
    PLoS One. 2026;21:e0351464.
    PubMed         Abstract available
    
    
22. FERDOUSY TJ, Hasan Miraz MM, Al Arian T, Afif Ullah M, et al
    Design of a novel epitope-based tetravalent subunit vaccine against dengue virus: An immunoinformatic approach.
    PLoS One. 2026;21:e0354891.
    PubMed         Abstract available
    
    
23. BRANNON GE, Chatterjee K, Jang CY, Markham Shaw C, et al
    Perceptions of Spanish-language COVID-19 video messaging among the Hispanic community: A qualitative study in the United States of America.
    PLoS One. 2026;21:e0339634.
    PubMed         Abstract available
    
    

    
    Vaccine

24. MARTINO A, Urrego-Reyes J, Cervenka J, Paluru MK, et al
    Invasive pneumococcal disease in Latin America: serotype distribution and vaccine coverage among adults in Mexico, Brazil, and Argentina.
    Vaccine. 2026;88:128947.
    PubMed         Abstract available
    
    
25. KYESI F, Michael F, Kilonzo S, Misinzo G, et al
    Prioritizing the introduction of new vaccine in Tanzania (2026-2030): a multi-criteria decision analysis by the Tanzania immunization technical advisory group.
    Vaccine. 2026;88:128985.
    PubMed         Abstract available
    
    
26. WEI Z, Feng X, Sun Q, Chen D, et al
    Factors affecting parental practices and attitudes toward influenza vaccination for children in China.
    Vaccine. 2026;88:128988.
    PubMed         Abstract available
    
    
27. TAY CJX, Koh CWT, Ooi JSG, Li HE, et al
    Over-induction of innate immune responses suppresses T cell response to mRNA SARS-CoV-2 vaccination.
    Vaccine. 2026;88:128983.
    PubMed         Abstract available
    
    
28. NIINIKOSKI V, Myllyla A, Barkoff AM, He Q, et al
    Polymorphisms in the Bordetella pertussis virulence factor SphB1 and altered antigen expression of clinical isolates before and after acellular pertussis vaccination in Finland.
    Vaccine. 2026;88:128979.
    PubMed         Abstract available
    
    
29. KOSTANYAN L, Fukase H, Rumyantsev A, Hashizume K, et al
    Immunogenicity, reactogenicity, and safety of an mRNA-based seasonal influenza and SARS-CoV-2 multicomponent vaccine, mRNA-1083, in adults aged >/=50 years in Japan.
    Vaccine. 2026;88:128961.
    PubMed         Abstract available
    
    
30. LI L, Liu X, Yan D, Shuo D, et al
    Tembusu virus-vectored chimeric vaccine induces potent neutralizing antibody response against West Nile virus in ducks.
    Vaccine. 2026;88:128933.
    PubMed         Abstract available
    
    
31. ERBS G, Lybeck K, Jakobsen JT, Nguyen LTM, et al
    Multi-peptide subunit vaccination induced IFN-gamma but lacked efficacy against Mycobacterium avium subsp. paratuberculosis in a goat challenge trial.
    Vaccine. 2026;88:128971.
    PubMed         Abstract available
    
    
32. MAEDA H, Igarashi A, Mitsui S, Suzuki K, et al
    Interim analysis of effectiveness of JN.1-adapted conventional and self-amplifying mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infection in adults aged >/=60 years, Japan, October 2024-April 2025.
    Vaccine. 2026;88:128964.
    PubMed         Abstract available
    
    
33. LIU B, Li F, Yang Y, Tu H, et al
    In-depth monitoring of host cell proteins in influenza vaccines throughout multi-step purification processes.
    Vaccine. 2026;88:128957.
    PubMed         Abstract available
    
    
34. BENITO P, Aldea M, Godoy P, Toledo D, et al
    Rubella immunity and vaccination coverage among medical students in Catalonia: a multicentre seroprevalence study.
    Vaccine. 2026;88:128968.
    PubMed         Abstract available
    
    
35. BARASA L, Onyango G
    The institutional roots of vaccine uptake and hesitancy: evidence from Africa.
    Vaccine. 2026;88:128980.
    PubMed         Abstract available
    
    
36. SAITOH A, Takaku M
    Erratum to "Partner awareness and support for maternal RSV vaccination: a paired survey of pregnant women and co-residing partners in Japan" [Vaccine 88 (2026) 128946].
    Vaccine. 2026 Jul 27:128966. doi: 10.1016/j.vaccine.2026.128966.
    PubMed        
    
    
37. KIM T, Wang X, Rajtmajer S, Harden JJ, et al
    Elected officials' online anti-vaccination statements respond to online engagement.
    Vaccine. 2026;88:128901.
    PubMed         Abstract available
    
    
38. C M, Dymock M, Flanagan KL, Plebanski M, et al
    The Platform trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity and safety of seven licensed COVID-19 vaccines delivered as fifth dose or subsequent boosters in immunocompetent adults.
    Vaccine. 2026;88:128970.
    PubMed         Abstract available
    
    
39. KONLAN M, Bhandari R, Adjei MR, Owusu SA, et al
    Beyond coverage: Timeliness of routine childhood vaccination and its determinants in rural northern Ghana.
    Vaccine. 2026;88:128981.
    PubMed         Abstract available
    
    
40. VAN MEIJEREN DL, van Roon AM, de Gier B, Huiberts AJ, et al
    High effectiveness of infant vaccination against pertussis in 1- and 2-year-olds, the Netherlands, 2013-2024.
    Vaccine. 2026;88:128978.
    PubMed         Abstract available
    
    
41. PILLSBURY A, Nguyen T, Dawes L, Young J, et al
    More than 10 years of Australia's AusVaxSafety (2014-2026): an adaptable model of a participant-powered active vaccine safety surveillance system.
    Vaccine. 2026;88:128928.
    PubMed        
    
    
42. DE PADUA MC, Antunes MOB, Stein RT, Pinto LA, et al
    Effectiveness of BNT162B2 and CoronaVac vaccines in reducing COVID-19 severity among children aged 3-4 years in Brazil.
    Vaccine. 2026;88:128974.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum